Treeline Biosciences

Medicines, elevated

Watertown, United States · Founded 2021 · $821.8M raised

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$821.8M
Last Round
$200.0M Extension RoundSep 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Treeline Biosciences is a clinical-stage biopharma developing precision medicines for cancer, autoimmune, and neurological diseases. The company integrates in-house biology, chemistry, protein science, and computational/ML tools to advance a pipeline of inhibitors, protein degraders, and antibody drug conjugates through human clinical trials.

Summary

Treeline Biosciences is a Biotech company based in Watertown, United States, founded in 2021. It has raised $821.8M in total across 3 rounds, most recently a $200.0M Extension Round in Sep 2025. Investors include The GBA Fund, GV and HM Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A ExtensionSep 2025
$200.0M

Sign up to see all 3 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Treeline Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/treeline-biosciences"><img src="https://indexed.vc/api/badge/company/treeline-biosciences" alt="Treeline Biosciences on Indexed.vc" width="260" height="76" /></a>